ZEPP Quote, Financials, Valuation and Earnings

Elastic NV has a net margin of -51.23% compared to Zepp Health's net margin of -4.22%. Zepp Health's return on equity of -27.58% beat Elastic NV's return on equity of -13.2%.

Zepp Health has a consensus price target of $12.32, signalling downside risk potential of -4.87%. On the other hand Elastic NV has an analysts' consensus of $111.61 which suggests that it could grow by 31.24%. Given that Elastic NV has higher upside potential than Zepp Health, analysts believe Elastic NV is more attractive than Zepp Health.

Zepp Health has a beta of 0.854, which suggesting that the stock is 14.569% less volatile than S&P 500. In comparison Elastic NV has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.587%.

Zepp Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elastic NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zepp Health pays -- of its earnings as a dividend. Elastic NV pays out -- of its earnings as a dividend.

Zepp Health quarterly revenues are $38.5M, which are smaller than Elastic NV quarterly revenues of $388.4M. Zepp Health's net income of -$19.7M is lower than Elastic NV's net income of -$16.4M. Notably, Zepp Health's price-to-earnings ratio is -- while Elastic NV's PE ratio is 184.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zepp Health is 1.15x versus 5.94x for Elastic NV. Usually stocks with elevated PS ratios are considered overvalued.

Nedap NV has a net margin of -51.23% compared to Zepp Health's net margin of --. Zepp Health's return on equity of -27.58% beat Nedap NV's return on equity of 22.92%.

Zepp Health has a consensus price target of $12.32, signalling downside risk potential of -4.87%. On the other hand Nedap NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Zepp Health has higher upside potential than Nedap NV, analysts believe Zepp Health is more attractive than Nedap NV.

Zepp Health has a beta of 0.854, which suggesting that the stock is 14.569% less volatile than S&P 500. In comparison Nedap NV has a beta of -0.119, suggesting its less volatile than the S&P 500 by 111.888%.

Zepp Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nedap NV offers a yield of 5.1% to investors and pays a quarterly dividend of $3.63 per share. Zepp Health pays -- of its earnings as a dividend. Nedap NV pays out 113.8% of its earnings as a dividend.

Zepp Health quarterly revenues are $38.5M, which are larger than Nedap NV quarterly revenues of --. Zepp Health's net income of -$19.7M is higher than Nedap NV's net income of --. Notably, Zepp Health's price-to-earnings ratio is -- while Nedap NV's PE ratio is 23.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zepp Health is 1.15x versus 1.74x for Nedap NV. Usually stocks with elevated PS ratios are considered overvalued.

NXP Semiconductors NV has a net margin of -51.23% compared to Zepp Health's net margin of 17.28%. Zepp Health's return on equity of -27.58% beat NXP Semiconductors NV's return on equity of 24.88%.

Zepp Health has a consensus price target of $12.32, signalling downside risk potential of -4.87%. On the other hand NXP Semiconductors NV has an analysts' consensus of $245.40 which suggests that it could grow by 11.25%. Given that NXP Semiconductors NV has higher upside potential than Zepp Health, analysts believe NXP Semiconductors NV is more attractive than Zepp Health.

Zepp Health has a beta of 0.854, which suggesting that the stock is 14.569% less volatile than S&P 500. In comparison NXP Semiconductors NV has a beta of 1.405, suggesting its more volatile than the S&P 500 by 40.51%.

Zepp Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NXP Semiconductors NV offers a yield of 1.84% to investors and pays a quarterly dividend of $1.01 per share. Zepp Health pays -- of its earnings as a dividend. NXP Semiconductors NV pays out 41.36% of its earnings as a dividend. NXP Semiconductors NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Zepp Health quarterly revenues are $38.5M, which are smaller than NXP Semiconductors NV quarterly revenues of $2.8B. Zepp Health's net income of -$19.7M is lower than NXP Semiconductors NV's net income of $490M. Notably, Zepp Health's price-to-earnings ratio is -- while NXP Semiconductors NV's PE ratio is 24.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zepp Health is 1.15x versus 4.60x for NXP Semiconductors NV. Usually stocks with elevated PS ratios are considered overvalued.

TomTom NV has a net margin of -51.23% compared to Zepp Health's net margin of -16.16%. Zepp Health's return on equity of -27.58% beat TomTom NV's return on equity of -23.01%.

Zepp Health has a consensus price target of $12.32, signalling downside risk potential of -4.87%. On the other hand TomTom NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Zepp Health has higher upside potential than TomTom NV, analysts believe Zepp Health is more attractive than TomTom NV.

Zepp Health has a beta of 0.854, which suggesting that the stock is 14.569% less volatile than S&P 500. In comparison TomTom NV has a beta of 1.335, suggesting its more volatile than the S&P 500 by 33.494%.

Zepp Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TomTom NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zepp Health pays -- of its earnings as a dividend. TomTom NV pays out -- of its earnings as a dividend.

Zepp Health quarterly revenues are $38.5M, which are smaller than TomTom NV quarterly revenues of $165.8M. Zepp Health's net income of -$19.7M is higher than TomTom NV's net income of -$26.8M. Notably, Zepp Health's price-to-earnings ratio is -- while TomTom NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zepp Health is 1.15x versus 1.26x for TomTom NV. Usually stocks with elevated PS ratios are considered overvalued.